期刊
PEDIATRICS
卷 133, 期 1, 页码 156-163出版社
AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2013-3443
关键词
surfactant; antenatal steroids; respiratory distress syndrome; meconium aspiration syndrome; neonatal pneumonia; neonatal sepsis; congenital diaphragmatic hernia; pulmonary hemorrhage; persistent pulmonary hypertension; preterm; term
类别
Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late-preterm and term neonates with meconium aspiration syndrome, pneumonia/sepsis, and perhaps pulmonary hemorrhage; surfactant replacement may be beneficial for these infants. This statement summarizes the evidence regarding indications, administration, formulations, and outcomes for surfactant-replacement therapy. The clinical strategy of intubation, surfactant administration, and extubation to continuous positive airway pressure and the effect of continuous positive airway pressure on outcomes and surfactant use in preterm infants are also reviewed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据